Literature DB >> 31015912

Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria.

Ross D Ballantine1, Conor E McCallion1, Elie Nassour2, Sima Tokajian2, Stephen A Cochrane1.   

Abstract

Antimicrobial peptides are a rich source of potential antibiotic candidates. The tridecaptins, a family of linear lipo-tridecapeptides, are easily synthesized and show strong activity against Gram-negative bacteria. However, their composition includes several expensive amino acids, such as d/l diaminobutyric acid and d-allo-isoleucine, significantly increasing their cost of synthesis. Herein, we report a series of new tridecaptin derivatives that are much cheaper to synthesize and retain strong activity against multidrug-resistant Gram-negative bacteria.

Entities:  

Year:  2019        PMID: 31015912      PMCID: PMC6457190          DOI: 10.1039/c9md00031c

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  16 in total

1.  Synthesis and structure-activity relationship studies of N-terminal analogues of the antimicrobial peptide tridecaptin A(1).

Authors:  Stephen A Cochrane; Christopher T Lohans; Jeremy R Brandelli; George Mulvey; Glen D Armstrong; John C Vederas
Journal:  J Med Chem       Date:  2014-01-30       Impact factor: 7.446

2.  Unacylated tridecaptin A₁ acts as an effective sensitiser of Gram-negative bacteria to other antibiotics.

Authors:  Stephen A Cochrane; John C Vederas
Journal:  Int J Antimicrob Agents       Date:  2014-09-27       Impact factor: 5.283

3.  Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.

Authors:  Stephen A Cochrane; Brandon Findlay; Alireza Bakhtiary; Jeella Z Acedo; Eva M Rodriguez-Lopez; Pascal Mercier; John C Vederas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-29       Impact factor: 11.205

Review 4.  Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates.

Authors:  Stephen A Cochrane; John C Vederas
Journal:  Med Res Rev       Date:  2014-05-28       Impact factor: 12.944

5.  Antibiotic Resistance.

Authors:  Idan Yelin; Roy Kishony
Journal:  Cell       Date:  2018-02-22       Impact factor: 41.582

6.  Biochemical, structural, and genetic characterization of tridecaptin A₁, an antagonist of Campylobacter jejuni.

Authors:  Christopher T Lohans; Marco J van Belkum; Stephen A Cochrane; Zedu Huang; Clarissa S Sit; Lynn M McMullen; John C Vederas
Journal:  Chembiochem       Date:  2013-12-30       Impact factor: 3.164

7.  Studies on tridecaptin B(1), a lipopeptide with activity against multidrug resistant Gram-negative bacteria.

Authors:  Stephen A Cochrane; Christopher T Lohans; Marco J van Belkum; Manon A Bels; John C Vederas
Journal:  Org Biomol Chem       Date:  2015-06-07       Impact factor: 3.876

8.  Key residues in octyl-tridecaptin A1 analogues linked to stable secondary structures in the membrane.

Authors:  Stephen A Cochrane; Brandon Findlay; John C Vederas; Elaref S Ratemi
Journal:  Chembiochem       Date:  2014-05-09       Impact factor: 3.164

9.  Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria.

Authors:  Stephen A Cochrane; Xuefeng Li; Sisi He; Min Yu; Min Wu; John C Vederas
Journal:  J Med Chem       Date:  2015-12-04       Impact factor: 7.446

10.  Estimating the burden of antimicrobial resistance: a systematic literature review.

Authors:  Nichola R Naylor; Rifat Atun; Nina Zhu; Kavian Kulasabanathan; Sachin Silva; Anuja Chatterjee; Gwenan M Knight; Julie V Robotham
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

View more
  6 in total

1.  Turning a Collagenesis-Inducing Peptide Into a Potent Antibacterial and Antibiofilm Agent Against Multidrug-Resistant Gram-Negative Bacteria.

Authors:  Ana Gomes; Lucinda J Bessa; Iva Fernandes; Ricardo Ferraz; Nuno Mateus; Paula Gameiro; Cátia Teixeira; Paula Gomes
Journal:  Front Microbiol       Date:  2019-08-20       Impact factor: 5.640

2.  Comparative Genomics Insights into a Novel Biocontrol Agent Paenibacillus peoriae Strain ZF390 against Bacterial Soft Rot.

Authors:  Yurong Zhao; Xuewen Xie; Junhui Li; Yanxia Shi; Ali Chai; Tengfei Fan; Baoju Li; Lei Li
Journal:  Biology (Basel)       Date:  2022-08-04

Review 3.  The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria.

Authors:  Samantha J Bann; Ross D Ballantine; Stephen A Cochrane
Journal:  RSC Med Chem       Date:  2021-01-22

Review 4.  Development and Challenges of Antimicrobial Peptides for Therapeutic Applications.

Authors:  Charles H Chen; Timothy K Lu
Journal:  Antibiotics (Basel)       Date:  2020-01-13

5.  A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases.

Authors:  Samantha J Bann; Ross D Ballantine; Conor E McCallion; Pei-Yuan Qian; Yong-Xin Li; Stephen A Cochrane
Journal:  J Med Chem       Date:  2019-11-08       Impact factor: 7.446

Review 6.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.